PL3066108T3 - Octan 4-{4-[(1E)-4-(2,9-diazaspiro[5.5]undec-2-yIo)but-1-en-1-ylo]-2-metylobenzylo}-5-(propan-2-ylo)-1H-pirazol-3-ilo beta-D-glukopiranozydu - Google Patents

Octan 4-{4-[(1E)-4-(2,9-diazaspiro[5.5]undec-2-yIo)but-1-en-1-ylo]-2-metylobenzylo}-5-(propan-2-ylo)-1H-pirazol-3-ilo beta-D-glukopiranozydu

Info

Publication number
PL3066108T3
PL3066108T3 PL14802974T PL14802974T PL3066108T3 PL 3066108 T3 PL3066108 T3 PL 3066108T3 PL 14802974 T PL14802974 T PL 14802974T PL 14802974 T PL14802974 T PL 14802974T PL 3066108 T3 PL3066108 T3 PL 3066108T3
Authority
PL
Poland
Prior art keywords
diazaspiro
undec
methylbenzyl
pyrazol
propan
Prior art date
Application number
PL14802974T
Other languages
English (en)
Inventor
Susan Marie Reutzel-Edens
Original Assignee
Eli Lilly And Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly And Company filed Critical Eli Lilly And Company
Publication of PL3066108T3 publication Critical patent/PL3066108T3/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D221/00Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/20Spiro-condensed ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/02Heterocyclic radicals containing only nitrogen as ring hetero atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/7056Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing five-membered rings with nitrogen as a ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/48Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D309/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/04Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D309/06Radicals substituted by oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13Crystalline forms, e.g. polymorphs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PL14802974T 2013-11-08 2014-10-30 Octan 4-{4-[(1E)-4-(2,9-diazaspiro[5.5]undec-2-yIo)but-1-en-1-ylo]-2-metylobenzylo}-5-(propan-2-ylo)-1H-pirazol-3-ilo beta-D-glukopiranozydu PL3066108T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361901488P 2013-11-08 2013-11-08
EP14802974.7A EP3066108B1 (en) 2013-11-08 2014-10-30 4-{4-[(1e)-4-(2,9-diazaspiro[5.5]undec-2-yl)but-1-en-1-yl]-2-methylbenzyl}-5-(propan-2-yl)-1h-pyrazol-3-yl beta-d- glucopyranoside acetate
PCT/US2014/063161 WO2015069541A1 (en) 2013-11-08 2014-10-30 4-{4-[(1 e)-4-(2,9-diazaspiro[5.5]undec-2-yl)but-1 -en-1 -yl]-2-methylbenzyl}-5-(propan-2-yl)-1 h-pyrazol-3-yl beta-d- glucopyranoside acetate

Publications (1)

Publication Number Publication Date
PL3066108T3 true PL3066108T3 (pl) 2019-03-29

Family

ID=51982747

Family Applications (1)

Application Number Title Priority Date Filing Date
PL14802974T PL3066108T3 (pl) 2013-11-08 2014-10-30 Octan 4-{4-[(1E)-4-(2,9-diazaspiro[5.5]undec-2-yIo)but-1-en-1-ylo]-2-metylobenzylo}-5-(propan-2-ylo)-1H-pirazol-3-ilo beta-D-glukopiranozydu

Country Status (35)

Country Link
US (1) US9573970B2 (pl)
EP (1) EP3066108B1 (pl)
JP (1) JP6197113B2 (pl)
KR (1) KR101858881B1 (pl)
CN (1) CN105705509B (pl)
AP (1) AP2016009180A0 (pl)
AR (2) AR098670A1 (pl)
AU (1) AU2014347065B2 (pl)
CA (1) CA2925128C (pl)
CL (1) CL2016000791A1 (pl)
CR (1) CR20160165A (pl)
CY (1) CY1121096T1 (pl)
DK (1) DK3066108T3 (pl)
DO (1) DOP2016000067A (pl)
EA (1) EA028801B1 (pl)
ES (1) ES2703944T3 (pl)
HR (1) HRP20182061T1 (pl)
IL (1) IL244899B (pl)
JO (1) JO3485B1 (pl)
LT (1) LT3066108T (pl)
MA (1) MA39019A1 (pl)
MX (1) MX368174B (pl)
MY (1) MY192242A (pl)
NZ (1) NZ718118A (pl)
PE (1) PE20160884A1 (pl)
PH (1) PH12016500851B1 (pl)
PL (1) PL3066108T3 (pl)
PT (1) PT3066108T (pl)
RS (1) RS58050B1 (pl)
SI (1) SI3066108T1 (pl)
SV (1) SV2016005190A (pl)
TN (1) TN2016000112A1 (pl)
TW (1) TWI655198B (pl)
UA (1) UA118767C2 (pl)
WO (1) WO2015069541A1 (pl)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3256156B1 (en) * 2015-02-13 2025-02-12 Transgene Immunotherapeutic vaccine and antibody combination therapy
JP2020523394A (ja) * 2017-06-12 2020-08-06 リグナメッド・エルエルシーLignamed,Llc (s,s)−セコイソラリシレシノールジグルコシド及び(r,r)−セコイソラリシレシノールジグルコシドの製造方法
CN110054657B (zh) * 2018-01-18 2021-06-29 亚宝药业集团股份有限公司 吡喃葡萄糖取代的吡唑化合物及其制备方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0013667B8 (pt) 1999-08-31 2021-05-25 Kissei Pharmaceutical derivados de glucopiranosiloxipirazol, composições medicinais contendo os mesmos e seus intermediários na produção deles
WO2002068439A1 (fr) 2001-02-26 2002-09-06 Kissei Pharmaceutical Co., Ltd. Derives de glycopyranosyloxypyrazole et utilisation medicinale de ceux-ci
EP1400529A4 (en) 2001-05-30 2007-12-19 Kissei Pharmaceutical GLUCOPYRANOSYLOXYPYRAZOLE DERIVATIVE, MEDICINAL COMPOSITION CONTAINING THE SAME, AND MEDICINAL AND INTERMEDIARY USE THEREOF
ZA200501094B (en) * 2002-08-08 2006-10-25 Kissei Pharmaceutical Pyrazole derivative, medicinal composition containing the same, medicinal use thereof, and intermediate for production thereof
BRPI0313290B1 (pt) 2002-08-08 2016-12-06 Kissei Pharmaceutical derivados de pirazol, promedicamento, composição farmacêutica, agentes terapêuticos e uso medicinal
JP2004137245A (ja) 2002-08-23 2004-05-13 Kissei Pharmaceut Co Ltd ピラゾール誘導体、それを含有する医薬組成物、その医薬用途及びその製造中間体
DE102004028241B4 (de) * 2004-06-11 2007-09-13 Sanofi-Aventis Deutschland Gmbh Neue Fluorglykosidderivate von Pyrazolen, diese Verbindungen enthaltende Arzneimittel und Herstellung dieser Arzneimittel
AR061026A1 (es) * 2006-05-19 2008-07-30 Taisho Pharmaceutical Co Ltd Compuesto glicitol c-fenilo y preparacion farmaceutica
CA2709530C (en) 2007-12-27 2016-02-23 Kissei Pharmaceutical Co., Ltd. Monosebacate of pyrazole derivative
MY155658A (en) 2009-02-23 2015-11-13 Taisho Pharmaceutical Co Ltd A-isopropylphenyl glucitol compounds as sglti inhibitors
WO2011039338A2 (en) 2009-10-02 2011-04-07 Sanofi-Aventis Use of compounds with sglt-1/sglt-2 inhibitor activity for producing medicaments for treatment of bone diseases
US8163704B2 (en) 2009-10-20 2012-04-24 Novartis Ag Glycoside derivatives and uses thereof
UA113086C2 (xx) * 2012-05-10 2016-12-12 Піразольні сполуки як інгібітори sglt1

Also Published As

Publication number Publication date
CY1121096T1 (el) 2019-12-11
DOP2016000067A (es) 2016-04-15
MX368174B (es) 2019-09-23
MY192242A (en) 2022-08-10
ES2703944T3 (es) 2019-03-13
DK3066108T3 (da) 2019-01-02
EA201690749A1 (ru) 2016-08-31
JP2016539099A (ja) 2016-12-15
AR098670A1 (es) 2016-06-08
MA39019A1 (fr) 2017-04-28
US9573970B2 (en) 2017-02-21
IL244899A0 (en) 2016-05-31
JP6197113B2 (ja) 2017-09-13
PT3066108T (pt) 2018-11-29
CR20160165A (es) 2016-06-08
AP2016009180A0 (en) 2016-04-30
PH12016500851B1 (en) 2020-02-19
NZ718118A (en) 2017-11-24
KR101858881B1 (ko) 2018-05-16
EP3066108B1 (en) 2018-10-24
EP3066108A1 (en) 2016-09-14
US20160215011A1 (en) 2016-07-28
AU2014347065B2 (en) 2016-09-29
RS58050B1 (sr) 2019-02-28
SV2016005190A (es) 2018-11-01
CA2925128C (en) 2017-10-17
AU2014347065A1 (en) 2016-04-07
SI3066108T1 (sl) 2018-12-31
UA118767C2 (uk) 2019-03-11
IL244899B (en) 2019-10-31
TN2016000112A1 (en) 2017-07-05
CL2016000791A1 (es) 2016-11-11
CN105705509A (zh) 2016-06-22
TW201609783A (zh) 2016-03-16
WO2015069541A1 (en) 2015-05-14
LT3066108T (lt) 2019-01-25
KR20160067157A (ko) 2016-06-13
HRP20182061T1 (hr) 2019-02-08
CN105705509B (zh) 2018-12-04
EA028801B1 (ru) 2017-12-29
PH12016500851A1 (en) 2016-06-20
TWI655198B (zh) 2019-04-01
PE20160884A1 (es) 2016-09-10
JO3485B1 (ar) 2020-07-05
AR124083A2 (es) 2023-02-08
MX2016005999A (es) 2016-07-22
CA2925128A1 (en) 2015-05-14

Similar Documents

Publication Publication Date Title
PL2984076T3 (pl) Estry i etery 2,5-tetrahydrofuranu jako plastyfikatory
EP3038466A4 (en) 2,2-difluorodioxolo a2a receptor antagonists
EP3025175A4 (en) Single large mode cladding amplification in active double-clad fibers
EP2985282A4 (en) Glutarimide derivatives, use thereof, pharmaceutical composition based thereon and methods for producing glutarimide derivatives
PL2912030T3 (pl) Ulepszony sposób wytwarzania 5-(2,6-di-4-morfolinylo-4-pirymidynylo)-4- trifluorometylopirydyno-2-aminy
EP3016936A4 (en) Process for preparing clomazone, novel form and use of the same
IL236081A (en) METHOD FOR PRODUCING 4- [5- (pyridine-4-ram) -1,2,4- h1- triazole-3-ram] pyridine-2-carbonitrile and intermediate phase thereof
EP3095328A4 (en) Prolonged-action acaricide composition and production method, acaricide strip and method for controlling the varroa destructor mite
IL267303B (en) Method for the production of -7-(3,4-dichloro-2-fluorophenylamino)-4)-4)-1 methoxyquinazolin-6-yloxy)piperidin-1-yl)prop-2-en-1-one
EP3007256A4 (en) Electrode binder composition, and electrode
IL252744A0 (en) Solid forms comprising (1E,4E)-2-amino-N,N-dipropyl-8-(4-(pyrrolidine-1-carbonyl)phenyl)-3H-benzo[bi]azepine-4-carboxamide, their preparations and their uses
PT3066108T (pt) Acetato de 4-{4-[(1e)-4-(2,9-diazaspiro[5,5]undec-2-il)but-1-en-1-il]-2-metilbenzil}-5-(propan-2-il)-1h-pirazol-3-il beta-d-glucopiranósido
EP3009568A4 (en) Asymmetric frame for retaining piles and machine for the production thereof
EP3319158A4 (en) FRAMEWORK FOR FUEL CELL AND FUEL CELL STACK STRUCTURE THEREWITH
TH1601002568A (th) 4-{4-[(1e)-4-(2,9-ไดอะซะสไพโร[5.5]อันเดค-2-อิล)บิวท์-1-เอ็น-1-อิล]-2- เมธิลเบนซิล}-5-(โพรแพน-2-อิล)-1h-ไพเเรซอล-3-อิล เบทา-d-กลูโคไพแรโนไซด์ แอซิเทท
Stake et al. Partnering-en form av samarbete: En fallstudie av partneringsprojektet Brygguddens Etapp 1 i Karlstad
AU2013904145A0 (en) secret connectors no.1
AU2013904769A0 (en) My Personal Relief, My Pal
AU2017901242A0 (en) Improvements in biodiesel production
AU2015903233A0 (en) Improvements in bedding
AU2015902784A0 (en) Improvements in Bedding
AU2013904452A0 (en) SCUM-Australian Whiskey, Australia's Spirit!
AU2013904119A0 (en) Rolla bale
AU2013903682A0 (en) Hay bale feeder
AU2013121V (en) Honey Lite Prunus persica var. nucipersica